We seem to — finally — be one step closer.
consisting of approximately 6,700 children ages 6 and under, the Moderna vaccine, administered in two 25 microgram doses 28 days apart, was 43.7% effective in preventing COVID-19 in children 6 months to 2 years old, and 37.5% effective in the 2 to 6 age group.
None of the children enrolled in the study developed severe symptoms, were hospitalized or were diagnosed with multisystem inflammatory syndrome . There were also no cases of myocarditis or pericarditis, an inflammation of the heart that had been reported in a small number of patients, primarily young men, after the second shot of the Pfizer or Moderna vaccines.
Because the study took place during the omicron surge, these findings presumably apply to infection with the omicron variant, and the lower rates of efficacy are consistent with observational data that omicron causes more breakthrough infections in adults., Moderna CEO Stéphane Bancel said he believes these results are “good news for parents of children under 6 years of age.”
“Given the need for a vaccine against COVID-19 in infants and young children we are working with the U.S. FDA and regulators globally to submit these data as soon as possible,” said Bancel.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Moderna says Covid vaccine for kids, 6 months to age 6, protects against severe diseaseThe shots didn't protect well against infection from the omicron variant in children, 6 months to age 6, although there were no cases of severe illness or deaths.
Lire la suite »
Vaccines protect against infection from Omicron subvariant — but not for longTwo doses of COVID vaccine cut the risk of infection and mild illness from the rising BA.2 subvariant, although protection wanes quickly.
Lire la suite »
BA.2 version of omicron is rising in the U.S., but experts remain optimisticThe recent omicron wave may protect against another major Covid surge.
Lire la suite »
Moderna says its low-dose COVID-19 vaccine works for kids younger than 6Moderna said in the coming weeks it would ask regulators in the U.S. and Europe to authorize two small-dose shots for youngsters younger than 6.
Lire la suite »
Moderna Will Seek Emergency Use Approval For Low-Dose Covid Vaccine In Kids Under 6I am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Lire la suite »
Moderna says vaccine for kids under 6 generates strong immune response'This interim analysis showed a robust neutralizing antibody response in both age groups.'
Lire la suite »